Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            March 16, 2020
            Published by admin on March 16, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

            Holzgerlingen, Germany, March 16, 2020, 08:00 am CET – Curetis N.V. (the “Company” and together with its subsidiaries “Curetis”), a developer of next-level molecular diagnostic solutions, […]
            Do you like it?0
            Read more
            March 13, 2020
            Published by admin on March 13, 2020
            Categories
            • GBC Blog

            First of 3 Diagnostic Tests for Coronavirus (COVID-19) Available from bioMérieux

            Business Wire – March 10, 2020 – bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, is announcing the forthcoming launch of 3 […]
            Do you like it?0
            Read more
            March 12, 2020
            Published by admin on March 12, 2020
            Categories
            • GBC Blog

            MicroRNA Signatures May Aid in Early Detection of Lung Cancer

            March 11, 2020, Leah Lawrence – Researchers say they can distinguish between lesions that are benign and those that could become invasive — but the technology […]
            Do you like it?0
            Read more
            March 12, 2020
            Published by admin on March 12, 2020
            Categories
            • GBC Blog

            U.S. Coronavirus Testing Threatened by Shortage of Critical Lab Materials

            By DAVID LIM and BRIANNA EHLEY 03/10/2020 06:56 PM EDT A looming shortage in lab materials is threatening to delay coronavirus test results and cause officials […]
            Do you like it?0
            Read more
            March 10, 2020
            Published by admin on March 10, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis N.V. Reports Results of the Extraordinary General Meeting

            Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, March 10, 2020, 14:15 pm CET – Curetis N.V. (the “Company” and together with its subsidiaries […]
            Do you like it?0
            Read more
            March 4, 2020
            Published by admin on March 4, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Epigenomics Request Triggers Centers for Medicare and Medicaid Services (CMS) Plan To Cover Colorectal Cancer Blood-Based Biomarker Tests

            03 Mar 2020 – MedTech Insights – The US Centers for Medicare and Medicaid Services is considering a national coverage determination for a blood-based biomarker screening […]
            Do you like it?0
            Read more
            March 2, 2020
            Published by admin on March 2, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Centers for Medicare & Medicaid Services (CMS) Open National Coverage Determination (NCD) Review Process for Epi proColon

            Berlin, 28.02.2020– Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) announces that the Centers for Medicare & Medicaid Services (CMS) have opened the National […]
            Do you like it?0
            Read more
            February 25, 2020
            Published by admin on February 25, 2020
            Categories
            • GBC Blog

            Biopharmaceutical Innovators Lead the Charge in Fight Against Coronavirus

            As the threat of the novel coronavirus continues to grow globally, innovative biopharmaceutical companies are ramping up efforts to study the virus and develop vaccines and […]
            Do you like it?0
            Read more
            February 20, 2020
            Published by admin on February 20, 2020
            Categories
            • GBC Blog

            GI Societies Issue Updated Colorectal Cancer Screening Recommendations

            Bethesda, Maryland (Feb. 18, 2020) – Patients at average risk of colorectal cancer who have a normal colonoscopy do not need to repeat screening for 10 […]
            Do you like it?0
            Read more
            Prev page
            1234567891011121314151617181920212223242526272829303132333435
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕